Glycosylation of immunoglobulin G is regulated by a large network of genes 
pleiotropic with inflammatory diseases

Klaric, L.; Tsepilov, Y. A.; Stanton, C. M.; Mangino, M.; Sikka, T. T.; Esko, T.; Pakhomov, E.; Salo, P.; Deelen, J.; McGurnaghan, S. J.; Keser, T.; Vuckovic, F.; Ugrina, I.; Kristic, J.; Gudelj, I.; Stambuk, J.; Plomp, R.; Pucic-Bakovic, M.; Pavic, T.; Vilaj, M.; Trbojevic-Akmacic, I.; Drake, C.; Dobrinic, P.; Mlinarec, J.; Jelusic, B.; Richmond, A.; Timofeeva, M.; Grishchenko, A. K.; Dmitrieva, J.; Bermingham, M. L.; Sharapov, S. Z.; Farrington, S. M.; Theodoratou, E.; Uh, H. W.; Beekman, M.; Slagboom, E. P.; Louis, E.; Georges, M.; Wuhrer, M.; Colhoun, H. M.; Dunlop, M. G.; Perola, M.; Fischer, K.; Polasek, O.; Campbell, H.; Rudan, I.; Wilson, J. F.; Zoldos, V.; Vitart, V.; Spector, T.; Aulchenko, Y. S.; Lauc, G.; Hayward, C.

doi:10.1126/sciadv.aax0301

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases

MPS-Authors

/persons/resource/persons276058

Deelen, J.
Deelen – Genetics and Biomarkers of Human Ageing, Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

https://www.ncbi.nlm.nih.gov/pubmed/32128391
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Klaric, L., Tsepilov, Y. A., Stanton, C. M., Mangino, M., Sikka, T. T., Esko, T., et al. (2020). Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases. Sci Adv, 6(8), eaax0301. doi:10.1126/sciadv.aax0301.

Cite as: https://hdl.handle.net/21.11116/0000-000B-307F-1

Abstract

Effector functions of immunoglobulin G (IgG) are regulated by the composition of a glycan moiety, thus affecting activity of the immune system. Aberrant glycosylation of IgG has been observed in many diseases, but little is understood about the underlying mechanisms. We performed a genome-wide association study of IgG N-glycosylation (N = 8090) and, using a data-driven network approach, suggested how associated loci form a functional network. We confirmed in vitro that knockdown of IKZF1 decreases the expression of fucosyltransferase FUT8, resulting in increased levels of fucosylated glycans, and suggest that RUNX1 and RUNX3, together with SMARCB1, regulate expression of glycosyltransferase MGAT3. We also show that variants affecting the expression of genes involved in the regulation of glycoenzymes colocalize with variants affecting risk for inflammatory diseases. This study provides new evidence that variation in key transcription factors coupled with regulatory variation in glycogenes modifies IgG glycosylation and has influence on inflammatory diseases.